Call for Abstract
Scientific Program
2nd International Conference and Exhibition on Dual Diagnosis, will be organized around the theme “Research strategies, advanced technologies and innovations in Dual Diagnosis”
Dual Diagnosis 2017 is comprised of 16 tracks and 121 sessions designed to offer comprehensive sessions that address current issues in Dual Diagnosis 2017.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Drug addiction is a case of physical dependence from a drug, where subject experience a withdrawal syndrome. Approximately half of individuals in the general population who have met criteria for a substance use disorder in their life will achieve recovery. In Australia nearly 30 million people are in recovery. In Europe, remission of alcohol and drug abuse is 78% & 68% respectively. In Asia, statistical evidence said that 55% of remission is observed.
- Track 1-1NSAIDS Addiction
- Track 1-2Cocaine addiction
- Track 1-3Hallucinogens Abuse
- Track 1-4Tobacco abuse
- Track 1-5Drug addiction diagnosis
- Track 1-6Drug addiction recovery
- Track 1-7Durg use and toxicity
- Track 1-8Cognitive impairment
- Track 1-9Psychodynamic therapy
- Track 1-10Addiction
In 2008, 3.5% to 5.7% of the world's population aged 15-64, used non-prescribed psychoactive medication. Globally cannabis usage is seen in 129-190 million people, next is amphetamines, cocaine and opioids. According to the American Medical Association 13.5 % of the US population has an Alcohol Abuse Disorder. Alcohol Abuse disorders are particularly common among bipolar disorders patients, with a long term prevalence of 50%. Nearly, US$ 200 billion-250 billion would be required to cover all costs related to drug treatment worldwide.
- Track 2-1Marijuana addiction
- Track 2-2Alcoholism
- Track 2-3Psychosis
- Track 2-4Schizophrenia
- Track 2-5Alcohol detoxification using chemotherapeutic agents
- Track 2-6Autism spectrum disorder
- Track 2-7Addiction and brain disorders
- Track 2-8alcoholism and brain
- Track 2-9Pain management
- Track 2-10Pharmacotherapies
- Track 2-11Alcoholic dementia
In 1800s and early 1900s, individuals dependent on opioids were primarily developed and from middle socioeconomic groups. However, since the 2000s, minorities and lower socioeconomic groups have been recognised with Opioid dependence. It shows availability of opioids and subcultural factors in opioid use.
- Track 3-1NSAIDS and Mental illness
- Track 3-2Drug addiction in Children and Adolescents
- Track 3-3Drug dependence
- Track 3-4Drug Abuse and Mental Health
- Track 3-5Drug induced disorders
- Track 3-6HIV/AIDS
- Track 3-7Alcohol and Viral Hepatitis
- Track 3-8Adaptive Immune System
- Track 3-9Lung Health and Immunity
- Track 3-10Alcoholic Liver Disease
- Track 3-11Neurogenetics of Substance Related Disorders
- Track 3-12Mental health and symptoms
Psychiatric disorders and Addiction occurs together in Dual diagnosis. Over 60% of drug abusers and 50% alcohol users have minimum one serious mental illness, all are diagnosed as mentally ill around 30% abuse alcohol, drugs.
Frequent psychiatric problems that occur with addiction are depressive disorders, anxiety disorders, and schizophrenia and personality disorders. People suffer from panic disorder or major depressive disorder is more often to abuse alcohol and drugs.
- Track 4-1Marijuana use
- Track 4-2Opioid dependence
- Track 4-3Opioid treatment
- Track 4-4Advances in addiction psychology
- Track 4-5Anxiety, Depression and Insomnia
- Track 4-6Attention-deficit hyperactivity disorder
- Track 4-7Obsessive-Compulsive Disorder
Alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, cannabis and opioids are commonly used drugs in drug abuse. Pharmacotherapies approved for treatment are replacement therapies such as buprenorphine and methadone. Antagonist medications like disulfiram and naltrexone. Other medications, that are effective includes bupropion and modafinil. Methadone and buprenorphine are effective on opiate addiction. Reports justify that 43.7 million Americans ages 15 experienced mental illness. In the past year, 25.7 million adults had a substance use disorder. In those 8.4 million people had both a mental disorder and substance use disorder, also known as co-occurring mental and drug use disorders.
- Track 5-1Addiction & Toxicology
- Track 5-2Alcohol detoxification using chemotherapeutic agents
- Track 5-3Alcoholic Liver Disease
- Track 5-4Lung Health and Immunity
Drugs commonly capable of recreational use are ethanol, cannabis, nicotine, caffeine, and substances within the scope of the United Nations' Single Convention on Narcotic Drugs and Psychotropic Substances. In 2012 it was estimated that about 3% to 6% of people use non-legal drugs. Domestic and International law enforcement agencies are occupied with interdiction efforts against illegal drug use, production, and circulation.
- Track 6-1 Post-traumatic stress disorder
- Track 6-2Emergency Mental health
- Track 6-3Antisocial Personality Disorder
- Track 6-4Behavioral addiction
- Track 6-5Sexual Addiction
- Track 6-6Gambling Addiction
- Track 6-7Internet Addiction
- Track 6-8Food addiction
- Track 6-9Surgical addiction
- Track 6-10 Alcoholism- Amnesia, anxiety, depression
- Track 6-11Amphetamines- schizophrenia
Globally cannabis usage is seen in 129-190 million people, next is amphetamines, cocaine and opioids. According to the American Medical Association 13.5 % of the US population has an Alcohol Abuse Disorder. Alcohol Abuse disorders are particularly common among bipolar disorders patients, with a long term prevalence of 50%. Nearly, US$ 200 billion-250 billion would be required to cover all costs related to drug treatment worldwide.
- Track 7-1 NSAIDS and Mental illness
- Track 7-2Drug addiction in Children and Adolescents
- Track 7-3Drug dependence
- Track 7-4Drug Abuse and Mental Health
- Track 7-5 Drug induced disorders
- Track 7-6 HIV/AIDS
- Track 7-7 Alcohol and Viral Hepatitis
Bipolar disorder is also commonly named as Manic-depressive illness, treated by mood stabilizers but sometimes, antidepressants and antipsychotics are used along with a mood stabilizer. Disorders in Anxiety are treated using b-blockers, anti-depressants and anti-anxiety medications. Drugs like Methylphenidate, Amphetamine which acts as stimulants are used to for Attention deficit hyperactivity disorder occurring in both adults and children. Many types of psychological treatments are proven to be effective.
- Track 8-1Personality disorder
- Track 8-2Anxiety disorders
- Track 8-3Bipolar depression
- Track 8-4Diagnosing bipolar test
- Track 8-5Manic bipolar disorder
- Track 8-6Bipolar schizophrenia
- Track 8-7Advanced therapeutics in Bipolar treatment
- Track 8-8 Bipolar Psychiatrists
Drug induced disorder is identified by use of one or many drugs results to a clinical impairment or distress. Alcohol related dementia is a form of dementia caused by long-term, excessive drinking, leads to neurological damage and impaired mental condition. Drugs like amphetamines, or its substitutes, are known to induce "Amphetamine psychosis" when they are abused.
- Track 9-1Clinical Depression
- Track 9-2Major Depression
- Track 9-3Advanced Depression
- Track 9-4Severe Depression
- Track 9-5 Advances in Depression test
- Track 9-6Advances in clinical depression disorders
- Track 9-7 Obsessive Compulsive Disorder
In 1800s and early 1900s, individuals dependent on opioids were primarily developed and from middle socioeconomic groups. However, since the 2000s, minorities and lower socioeconomic groups have been recognised with Opioid dependence. It shows availability of opioids and subcultural factors in opioid use. Therefore, medical professionals are at higher risk for developing opioid-related disorders.
- Track 10-1 Mental Health
- Track 10-2Emotional health
- Track 10-3 Behavioral health sciences
- Track 10-4Spiritual sciences
- Track 10-5Psychology and Education
- Track 10-6 Motivational interviewing
- Track 10-7 Contingency management
- Track 10-8 Residential treatment
- Track 10-9Psychodynamic therapy
- Track 10-10Dialectical behavioral therapy
- Track 10-11Cognitive impairment
Recent clinical studies have shown that between 30% and 60% of drug abusers have mental health diagnoses Depression, Schizophrenia, and Manic illness disorders. Drug Addiction is a typical of disorder involves the interaction of environmental factors and genetic factors to increase the susceptibility of an individual to addictive behaviour.
- Track 11-1Cannabis - hallucinations and delusions
- Track 11-2Cocaine - Dementia
- Track 11-3 Marijuana - Schizophrenia
- Track 11-4 Opioids - Insomnia
- Track 11-5 Ketamine - Antisocial personality disorders
- Track 11-6Benzodiazepine - Sedation & Hypnotism
- Track 11-7Advances in Neurotoxicology
- Track 11-8Substance abuse disorders
- Track 11-9Molecular Biology and Genetics
- Track 11-10Smoking
Dual diagnosis is the condition of suffering from a mental disorder and a co-occurring substance abuse problem. Any patient can have a "dual diagnosis" and treated primarily for an addiction disorder can have a “co-occurring mental disorder”. Like depression and alcoholism.
Addiction related brain and behaviour disorders, which include psychiatric diagnoses, like schizophrenia, mania, depressive disorder, and obsessive-compulsive disorder. Medical recognition of addiction, accept as a medical disorder, and treatment options for addiction is noticed in schizophrenia, manic illness disorder, and major depressive disorder. Similarly, major questions concern of pathology of addiction including the genetic and environmental factors, neurochemical and neurogenic changes, and the course of the illness.
Around half of alcoholics have mood disorders and more prevalent to have a major depressive disorder. Among people with Alcohol dependence, 37% meet the criteria for an anxiety disorder. Even tobacco use is linked to psychiatric disorders. In patients with depression, smoking prevalence rates are as high as 70%. Smoking rates are also elevated in people with panic disorder, posttraumatic stress disorder and schizophrenia.
Addictive disorder is a psychiatric chronic disease of brain reward system, motivation, and memory. Leads to inability to control behaviour, leads to habitual changes, and which affects a person from recovery of substance. Reason for Addictive disorder is substance abuse or activity that gives us pleasure and a genetic variance that increases our interest. Addiction is genetically developed in our psychological system, social and environmental factors that lead to excessive and prolonged usage, tolerance and withdrawal and negative consequences.
- Track 15-1Borderline personality therapy
- Track 15-2Integrated treatment for dual disorders
- Track 15-3Nicotine replacement therapy
- Track 15-4Cognitive behavioral therapy
- Track 15-5 Multidimensional family therapy
- Track 15-6Psychodynamic therapy
- Track 15-7 Dialectical behavioral therapy
- Track 15-8Prenatal Alcohol Exposure
- Track 15-9 Borderline personality therapy
- Track 15-10Integrated treatment for dual disorders
- Track 15-11Nicotine replacement therapy
- Track 15-12 Cognitive behavioral therapy
- Track 15-13 Multidimensional family therapy
- Track 15-14Psychodynamic therapy
- Track 15-15 Dialectical behavioral therapy
- Track 15-16 Prenatal Alcohol Exposure
Reports justify that 43.7 million Americans ages 15 experienced mental illness. In the past year, 25.7 million adults had a substance use disorder. In those 8.4 million people had both a mental disorder and substance use disorder, also known as co-occurring mental and drug use disorders.
Drug dependence is an adaptive state that results from repeated drug usage, and which results in withdrawal upon stopping drug use. Drug addiction is a different criterion from substance dependence, which is an addictive, unconditional drug use, results severe problems.
- Track 16-1Detoxification stage
- Track 16-2 Relapse and Management
- Track 16-3 Alcohol Facts
- Track 16-4 Drug abuse in the USA
- Track 16-5Trans cranial Magnetic Stimulation
- Track 16-6Psychotropic substance abusers
- Track 16-7Residential Drug Rehabilitation Program